Collagen Type V Antikörper

Produktnummer ABIN135054

Dieses Anti-Collagen Type V-Antikörper ist ein Ziege Polyklonal-Antikörper zur Detektion von Collagen Type V in ELISA. Geeignet für Human. Dieses Primary Antibody wurde in 3+ Publikationen zitiert.

Kurzübersicht für Collagen Type V Antikörper (ABIN135054)

Target: Collagen Type V (COL5) (Collagen, Type V (COL5))

Reaktivität: Human

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser Collagen Type V Antikörper ist unkonjugiert

Applikation: ELISA

Produktdetails anti-Collagen Type V Antikörper

Spezifität: Reacts with conformational determinants on type V collagen Referenced species reactivities include - Human 2,5,6,11,13,14,17,23-26 Chicken 4 Porcine 1,5,8 Mouse 3,12,20 Cuttlefish 27 Rabbit 9,15 Rat 5,7,10,16 Equine 19,21,22 Tree Shrew 18 Canine 5 Guinea Pig 15

Kreuzreaktivität (Details): Exhibits < 10 % cross reactivity with collagen type II, III, IV, V and VI. The antibody has not been tested for reactivity with other ECM proteins (e.g., laminin, fibronectin).

Produktmerkmale: Goat Anti-Type V Collagen-UNLB

Aufreinigung: Purification Method: Affinity chromatography on type V collagen covalently linked to agarose.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

• Applications: Quality tested applications include - ELISA ,
• Other referenced applications include - IHC-PS , IHC-FS , ICC , EM , WB
• Working Dilutions: ELISA BIOT conjugate 1:1,000 - 1:4,000

Probenmenge: 0,5 mL

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 0.4 mg/mL

Buffer: 0.2 mg of purified immunoglobulin in 0.5 mL of borate buffered saline,  pH 8.2. No preservatives or amine-containing buffer salts added

Konservierungsmittel: Without preservative

Handhabung: Each reagent is stable for the period shown on the bottle label if stored as directed.

Lagerung: 4 °C

Informationen zur Lagerung: Store at 2-8°C

Referenzen für anti-Collagen Type V Antikörper (ABIN135054)

Welc, Flores, Wehling-Henricks, Ramos, Wang, Bertoni, Tidball: "Targeting a therapeutic LIF transgene to muscle via the immune system ameliorates muscular dystrophy." in: Nature communications, Vol. 10, Issue 1, pp. 2788, (2019) (PubMed).

Finno, Gianino, Perumbakkam, Williams, Bordbari, Gardner, Burns, Peng, Durward-Akhurst, Valberg: "A missense mutation in MYH1 is associated with susceptibility to immune-mediated myositis in Quarter Horses." in: Skeletal muscle, Vol. 8, Issue 1, pp. 7, (2018) (PubMed).

Huang, Ge, Izzi, Greenspan: "α3 Chains of type V collagen regulate breast tumour growth via glypican-1." in: Nature communications, Vol. 8, pp. 14351, (2018) (PubMed).

Details zu Collagen Type V

Target: Collagen Type V (COL5) (Collagen, Type V (COL5))

Andere Bezeichnung: Type V Collagen